Gan & Lee Pharma, backed by Qiming Venture Partners and other venture investors, has completed an A-share listing in Shanghai. It issued 40.2 million new shares at the issue price of RMB 63.32 per share, raising a total of 2.54 billion yuan (US$359 million) in the initial offering. The company now has a market capitalization of around 36.6 billion yuan (US$5.2 billion).
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
